Antisense Therapeutics

Follow
Get notifications in MyBN when activity occurs. Upgrade your subscription to use this feature.

Company Activity

Default
NEW ROLE: Nuket Desem, 24 Nov 2020
Default
NEW ROLE: George Tachas, 24 Nov 2020
Default
NEW ROLE: Graham Mitchell, Non-Executive Director03 Nov 2020
Default
NEW ROLE: Gary W Pace, Non-Executive Director03 Nov 2020
Default
NEW ROLE: Robert W Moses, Non-Executive Chairman, Non-Executive Director03 Nov 2020
Default
NEW ROLE: Mark P Diamond, Chief Executive Officer, Managing Director03 Nov 2020
Default
NEW ROLE: William Goolsbee, Non-Executive Director03 Nov 2020
Default
NEW ROLE: Phillip Hains, Chief Financial Officer, Company Secretary03 Nov 2020

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options